Document Type
Article
Publication Date
3-1-2021
Abstract
With continually improving treatment strategies and patient care, the overall mortality of cardiovascular disease (CVD) has been significantly reduced. However, this success is a double-edged sword, as many patients who survive cardiovascular complications will progress towards a chronic disorder over time. A family of adiponectin paralogs designated as C1q complement/tumor necrosis factor (TNF)-associated proteins (CTRPs) has been found to play a role in the development of CVD. CTRPs, which are comprised of 15 members, CTRP1 to CTRP15, are secreted from different organs/tissues and exhibit diverse functions, have attracted increasing attention because of their roles in maintaining inner homeostasis by regulating metabolism, inflammation, and immune surveillance. In particular, studies indicate that CTRPs participate in the progression of CVD, influencing its prognosis. This review aims to improve understanding of the role of CTRPs in the cardiovascular system by analyzing current knowledge. In particular, we examine the association of CTRPs with endothelial cell dysfunction, inflammation, and diabetes, which are the basis for development of CVD. Additionally, the recently emerged novel coronavirus (COVID-19), officially known as severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has been found to trigger severe cardiovascular injury in some patients, and evidence indicates that the mortality of COVID-19 is much higher in patients with CVD than without CVD. Understanding the relationship of CTRPs and the SARS-CoV-2-related damage to the cardiovascular system, as well as the potential mechanisms, will achieve a profound insight into a therapeutic strategy to effectively control CVD and reduce the mortality rate.
Recommended Citation
Xie, Yaoli; Meng, Zhijun; Gao, Jia; Liu, Caihong; Wang, Jing; Guo, Rui; Zhao, Jianli; Lopez, Bernard; Christopher, Theodore; Lee, Daniel; Ma, Xin-Liang; and Wang, Yajing, "C1q complement/tumor necrosis factor-associated proteins in cardiovascular disease and covid-19" (2021). Department of Emergency Medicine Faculty Papers. Paper 133.
https://jdc.jefferson.edu/emfp/133
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Language
English
Comments
This article is the author’s final published version in Proteomes, Volume 9, Issue 1, March 2021, Article number 12.
The published version is available at https://doi.org/10.3390/proteomes9010012. Copyright © Xie et al.